Servier to Acquire Day One Biopharmaceuticals in $2.5 Billion Deal
Servier to acquire Day One Biopharmaceuticals in $2.5B deal, expanding its oncology portfolio and strengthening focus on rare and pediatric cancers.
Loading...
Servier to acquire Day One Biopharmaceuticals in $2.5B deal, expanding its oncology portfolio and strengthening focus on rare and pediatric cancers.
